The upcoming gathering will bring together researchers, clinicians, and policymakers from around the world to discuss the latest advancements in the study of retroviruses and related infections.
Attendees will explore cutting-edge research on HIV pathogenesis, novel antiretroviral therapies, and strategies to combat opportunistic infections that affect immunocompromised individuals.

San Diego's vibrant setting provides an ideal backdrop for this international event, fostering collaborations and knowledge exchange.
Participants can expect keynote speeches, interactive workshops, and poster sessions highlighting innovative findings from the past year.

Emphasis will be placed on global health equity, with sessions dedicated to improving access to treatments in low-resource settings.
The conference also addresses emerging challenges such as viral resistance and the intersection of retroviral infections with other comorbidities.

Networking opportunities abound, allowing early-career scientists to connect with established leaders in the field.
Exhibitions from pharmaceutical companies and research institutions will showcase new tools and technologies.